Clinical trial
A Long-term Study to Evaluate the Efficacy and Safety of AK102 in Combination With Lipid-lowering Therapy in Patients With Hypercholesterolemia
NCT04173403 is registered in ClinicalTrials.gov with Akeso as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Long-term Study to Evaluate the Efficacy and Safety of AK102 in Combination With Lipid-lowering Therapy in Patients With Hypercholesterolemia
- Lead sponsor
- Akeso
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 4, 2019
- Completion date
- February 17, 2023
- Enrollment
- 796 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.